Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Polonelli, Luciano ^a   Beninati, Concetta ^b   Teti, Giuseppe ^b   Felici, Franco ^c   Ciociola, Tecla ^a   Giovati, Laura ^a   Sperindè, Martina ^a   Lo Passo, Carla ^b   Pernice, Ida ^b   Domina, Maria ^b   Arigò, Milena ^b   Papasergi, Salvatore ^b   Mancuso, Giuseppe ^b   Conti, Stefania ^a   Magliani, Walter ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLCYSTEINYLHISTIDINYLPROPYLGLUTAMINYLGLYCYLARGINYLVALYLCYSTEINYLPHENYLALANYLHISTIDINE; ASPARTYLCYSTEINYLHISTIDINYLPROPYLGLUTAMINYLGLYCYLASPARAGINYLARGINYLPHENYLALANYLCYSTEINYLSERYLGLUTAMINE; BETA 1,3 GLUCAN; BETA 1,6 GLUCAN; DNA; GLYCYLCYSTEINYLVALYLHISTIDINYLASPARAGINYLISOLUECYLCYSTEINYLPHENYLALANYLALANINE; IDIOTYPIC ANTIBODY; ISOLEUCYLTYROSYLASPARAGINYLPHENYLALANYLISOLEUCYLASPARAGINYLGLUTAMINYLALANYLTRYPTOPHYLARGINYLHISTIDINYLALANINE; KEYHOLE LIMPET HEMOCYANIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AB6; MONOCLONAL ANTIBODY K10; MONOCLONAL ANTIBODY K20; MONOCLONAL ANTIBODY KT4; PEPTIDE; PROTEIN KTR; RECEPTOR; UNCLASSIFIED DRUG; YEAST KILLER FACTOR; ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; BETA GLUCAN; BETA-1,3-GLUCAN; BETA-1,6-GLUCAN; CELL SURFACE RECEPTOR; DNA VACCINE; FUNGAL PROTEIN; FUNGUS VACCINE; HEMOCYANIN; KEYHOLE-LIMPET HEMOCYANIN; KILLER TOXIN, PICHIA; MYCOTOXIN; PEPTIDE LIBRARY; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FEMALE; FUNGICIDAL ACTIVITY; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; MOUSE; NONHUMAN; PHAGE DISPLAY; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; CANDIDIASIS; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; MOLECULAR MIMICRY; PEPTIDE LIBRARY; PICHIA; RAT; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; BETA-GLUCANS; CANDIDA ALBICANS; CANDIDIASIS; FUNGAL PROTEINS; FUNGAL VACCINES; HEMOCYANIN; KILLER FACTORS, YEAST; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MYCOTOXINS; PEPTIDE LIBRARY; PEPTIDES; PICHIA; RATS; RECEPTORS, CELL SURFACE; VACCINATION; VACCINES, DNA; VACCINES, SUBUNIT;

EID: 84924795940     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105727     Document Type: Article

References (43)

1. Silverstein AM (1999) Paul Ehrlich's passion: The origins of his receptor immunology. Cell Immunol 194: 213-221.
2. Jerne NK (1974) Towards a network theory of the immune system. Ann Immunol (Paris) 125C: 373-389.
3. Oudin J, Michel M (1963) Une nouvelle forme d'allotypie des globulines gamma du sérum de lapin apparemment liée à la fonction et à la spécificité anticorps. C R Hebd Seances Acad Sci 257: 805-808.
4. Kunkel HG, Mannik M, Williams RC (1963) Individual antigenic specificity of isolated antibodies. Science 140: 1218-1219.
5. Cazenave PA (1977) Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proc Natl Acad Sci USA 74: 5122-5125.
6. Geha RS (1982) Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol 129: 139-144.
7. Cazenave PA, Roland J, Petit-Koskas E (1983) The idiotypic network: internal images of rabbit immunoglobulin allotopes. Ann Immunol (Paris) 134D: 7-16.
8. Bona CA (1998) Idiotype vaccines: forgotten but not gone. Nat Med 4: 668-669.
9. Hiernaux JR (1988). Idiotypic vaccines and infectious diseases. Infect Immun 56: 1407-1413.
10. Jerne NK, Roland J, Cazenave PA (1982). Recurrent idiotopes and internal images. EMBO J 1: 243-247.
11. Nisonoff A, Lamoyi E (1981) Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production. Clin Immunol Immunopathol 21: 397-406. (Pubitemid 12246077)
12. Ertl HC, Bona CA (1988) Criteria to define anti-idiotypic antibodies carrying the internal image of an antigen. Vaccine 6: 80-84. (Pubitemid 18089124)
13. Gaulton GN, Greene MI (1986) Idiotypic mimicry of biological receptors. Annu Rev Immunol 4: 253-280.
14. Polonelli L, Seguy N, Conti S, Gerloni M, Bertolotti D, et al. (1997) Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies. Clin Diagn Lab Immunol 4: 142-146. (Pubitemid 27130225)
15. Polonelli L, Morace G (1987) Production and characterization of yeast killer toxin monoclonal antibodies. J Clin Microbiol 25: 460-462. (Pubitemid 17232461)
16. Polonelli L, De Bernadis F, Conti S, Boccanera M, Magliani W, et al. (1996) Human natural yeast killer toxin-like candidacidal antibodies. J Immunol 156: 1880-1885. (Pubitemid 26072556)
17. Polonelli L, Lorenzini R, De Bernardis F, Gerloni M, Conti S, et al. (1993) Idiotypic vaccination: Immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity. Scand J Immunol 37: 105-110. (Pubitemid 23020908)
18. Magliani W, Conti S, Giovati L, Maffei DM, Polonelli L (2008) Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies. Front Biosci 13: 6920-6937.
19. Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, et al. (2005) A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202: 597-606. (Pubitemid 41258184)
20. Conti S, Cantelli C, Gerloni M, Fisicaro P, Magliani W, et al. (1996) Killer factor interference in mixed opportunistic yeast cultures. Mycopathologia 135: 1-8. (Pubitemid 27047835)
21. Magliani W, Conti S, De Bernardis F, Gerloni M, Bertolotti D, et al. (1997) Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat Biotechnol 15: 155-158. (Pubitemid 27081781)
22. Felici F, Castagnoli L, Musacchio A, Jappelli R, Cesareni G (1991) Selection of antibody ligands from a large library of oligopeptides expressed on a multivalent exposition vector. J Mol Biol 222: 301-310. (Pubitemid 121004008)
23. Luzzago A, Felici F (1998) Construction of disulfide-constrained random peptide libraries displayed on phage coat protein VIII. Methods Mol Biol 87: 155-164.
24. Beninati C, Garibaldi M, Lo Passo C, Mancuso G, Papasergi S, et al. (2009) Immunogenic mimics of lipopolysaccharide epitopes. Peptides 30: 1936-1939.
25. Falklind-Jerkérus S, Felici F, Cavalieri C, Lo Passo C, Garufi G, et al. (2005) Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response. Microbes Infect. 7: 1453-1460. (Pubitemid 41785719)
26. Beninati C, Midiri A, Mancuso G, Biondo C, Arigò M, et al. (2006) Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci. J Exp Med 203: 111-118. (Pubitemid 43139650)
27. Lo Passo C, Romeo A, Pernice I, Donato P, Midiri A, et al. (2007) Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization. J Immunol 178: 4417-4423. (Pubitemid 46492393)
28. Shearer MH, Dalgleish AG, Chanh TC, Kennedy RC (2000) Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity. AIDS Res Hum Retroviruses 16: 77-86. (Pubitemid 30036745)
29. Chang CC, Hernandez-Guzman FG, Luo W, Wang X, Ferrone S, et al. (2005) Structural basis of antigen mimicry in a clinically relevant melanoma antigen system. J Biol Chem 280: 41546-41552. (Pubitemid 41832216)
30. Vani J, Nayak R, Shaila MS (2007) Immunization of mice with DNA coding for the variable regions of anti-idiotypic antibody generates antigen-specific response. Vaccine 25: 4922-4930. (Pubitemid 46843433)
31. Pal S, Saha A, Mohanty K, Mallick P, Chatterjee SK, et al. (2007) Generation of Her-2/neu vaccine utilizing idiotypic network cascade. Cancer Biol Ther 6: 1916-1925. (Pubitemid 351590404)
32. Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, et al. (2007) Anti-tumor immunity by an anti-idiotype antibody mimicking human Her-2/neu. Breast Cancer Res Treat 104: 1-11. (Pubitemid 46976632)
33. Pignatari GC, Takeshita D, Parise CB, Soares FA, de Moraes JZ, et al. (2007) Carcinoembryonic antigen (CEA) mimicry by an anti-idiotypic scFv isolated from anti-Id 6.C4 hybridoma. J Biotechnol 127: 615-625. (Pubitemid 44959117)
34. Hernández AM, Toledo D, Martínez D, Griñán T, Brito V, et al. (2008) Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody. J Immunol 181: 6625-6634.
35. Lee G, Ge B (2010) Inhibition of in vitro tumor cell growth by RP215 monoclonal antibody and antibodies raised against its anti-idiotype antibodies. Cancer Immunol Immunother 59: 1347-1356.
36. Lim CS-Y, Rosli R, Seow HF, Chong PP (2012). Candida and invasive candidiasis: back to basics. Eur J Clin Microbiol Infect Dis 31: 21-31.
37. Roilides E (2011). Invasive candidiasis in neonates and children. Early Hum Dev 87 Suppl 1: S75-76.
38. Muñoz P, Guinea J, Rojas L, Bouza E (2010) New antifungal agents for the treatment of candidaemia. Int J Antimicrob Agents 36 Suppl 2: S63-69.
39. Moudgal V, Sobel J (2010) Antifungals to treat Candida albicans. Expert Opin Pharmacother 11: 2037-2048.
40. Magliani W, Conti S, Gerloni M, Bertolotti D, Polonelli L (1997) Yeast killer systems. Clin Microbiol Rev 10: 369-400. (Pubitemid 27359257)
41. Cassone A, Bromuro C, Chiani P, Torosantucci A (2010) Hyr1 protein and bglucan conjugates as anti-Candida vaccines. J Infect Dis 202: 1930.
42. Bromuro C, Romano M, Chiani P, Berti F, Tontini M, et al. (2010) Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 28: 2615-2623.
43. Vyas NK, Vyas MN, Chervenak MC, Bundle DR, Pinto BM, et al. (2003) Structural basis of peptide-carbohydrate mimicry in an antibody-combining site. Proc Natl Acad Sci USA 100: 15023-15028. (Pubitemid 37518010)